BioNJ is pleased that the Health Care Reform Act was passed. Our position prior to its passing appears below. BioNJ is in agreement with the general position advanced by BIO which contends that efforts to reform health care must address three general principles, each of which is a vital step toward meaningful health care reform… Read the full article

BioNJ is pleased that a regulatory pathway for biosimilars was included in the Health Care Reform Act. Our position prior to its inclusion and passage appears below. From its inception, the biotechnology industry has been driven by the application of cutting-edge science and innovative approaches and technologies that has resulted in the discovery, development and… Read the full article